-
DRG VARIATION IN LENGTH OF STAY AND POTENTIAL AVOIDABLE BED-DAYS: EVIDENCE FROM ROMANIA, 2023
Feb 25, 2026, 14:41 PM -
ACCESS TO HEALTHCARE, UTILIZATION, AND EXPENDITURES AMONG ADULTS WITH DIABETES AND CARDIORENAL COMORBIDITIES
Feb 25, 2026, 14:41 PM -
POTENTIAL BENEFITS OF RSV VACCINATION IN COLOMBIAN ADULTS AGED 60 AND OVER: A COST-UTILITY ANALYSIS
Feb 25, 2026, 14:41 PM -
EVALUATING ANALGESIC EFFICACY USING BUCHER AND ANCHORED MATCHING-ADJUSTED INDIRECT COMPARISON: A COMPARISON OF ANRIKEFON AND TEGILERIDINE
Feb 25, 2026, 14:41 PM -
PHARMACOECONOMIC EVALUATION OF DIFFERENT GONADOTROPIN-RELEASING HORMONE ANALOGS IN THE TREATMENT OF PREMENOPAUSAL HORMONE RECEPTOR-POSITIVE BREAST CANCER IN CHINA
Feb 25, 2026, 14:41 PM -
SLEEP DISORDER DIAGNOSIS IN ADOLESCENCE AND SUBSEQUENT MENTAL HEALTH DIAGNOSES - A RETROSPECTIVE COHORT STUDY
Feb 25, 2026, 14:41 PM -
IMPUTATION OF LONGITUDINAL OUTCOMES WHEN MISSINGNESS IS NOT AT RANDOM
Feb 25, 2026, 14:41 PM -
EARLY EXPERIENCE WITH THE EUROPEAN UNION JOINT CLINICAL ASSESSMENT (EUJCA): IMPLICATIONS FOR ONCOLOGY PRODUCTS
Feb 25, 2026, 14:41 PM -
PREPARING FOR THE NEXT ACCESS PARADIGM: TRANSITIONING FROM A REBATE-DOMINANT MARKET TO EU-STYLE EVIDENCE-BASED VALUE TO MAXIMIZE US PAYER COVERAGE
Feb 25, 2026, 14:41 PM -
PREVALENCE AND ASSOCIATION OF VITAMIN D DEFICIENCY WITH DIABETIC NEPHROPATHY IN TYPE 2 DIABETES, A HOSPITAL-BASED CROSS-SECTIONAL STUDY
Feb 25, 2026, 14:41 PM -
ACCESS TO GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST ANTIOBESITY MEDICATIONS: FORMULARY COVERAGE AND PRIOR AUTHORIZATION RESTRICTIONS ACROSS U.S. PAYERS
Feb 25, 2026, 14:41 PM -
ECONOMIC IMPACT OF AN AI-ENABLED DIGITAL TWIN INTERVENTION IN TYPE 2 DIABETES
Feb 25, 2026, 14:41 PM -
COST-EFFECTIVENESS OF PRECISION SCREENING FOR ATRIAL FIBRILLATION: A DECISION-ANALYTIC MODEL
Feb 25, 2026, 14:41 PM -
INCORPORATING PUBLISHED SUBGROUP ANALYSES INTO MULTILEVEL NETWORK META-REGRESSION VIA BAYESIAN SYNTHETIC LIKELIHOOD
Feb 25, 2026, 14:41 PM -
DEVELOPING A NOVEL PRO MEASURE IN MULTIPLE GLOBAL REGIONS AND LANGUAGES FOR KEY CONTRACEPTIVE SIDE EFFECTS
Feb 25, 2026, 14:41 PM -
MEASURING PATIENT-REPORTED DERMATOLOGIC SIDE EFFECTS OF CANCER TREATMENT: PSYCHOMETRIC EVALUATION OF THE SKINDEX-16 IN NON-SMALL CELL LUNG CANCER
Feb 25, 2026, 14:41 PM -
LIMITED PHARMACY ACCESS AND ITS POPULATION IMPACT: A GEOSPATIAL ANALYSIS OF SOUTH CAROLINA
Feb 25, 2026, 14:41 PM -
MAPPING PATIENT-REPORTED OUTCOMES EVIDENCE REQUIREMENTS ACROSS GLOBAL MARKETS
Feb 25, 2026, 14:41 PM -
COST-EFFECTIVENESS ANALYSIS OF DPYD-GUIDED FOLFOX IN UNRESECTABLE METASTATIC COLORECTAL CANCER IN THE US: A PATIENT-LEVEL MICROSIMULATION MODEL
Feb 25, 2026, 14:41 PM -
HEALTHCARE RESOURCE UTILIZATION FOLLOWING HUMAN METAPNEUMOVIRUS (HMPV) OR RESPIRATORY SYNCYTIAL VIRUS (RSV) DIAGNOSIS IN ADULTS: A RETROSPECTIVE, SELF-CONTROLLED, CLAIMS-BASED STUDY IN THE UNITED STATES
Feb 25, 2026, 14:41 PM
